<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">microcirculation</journal-id><journal-title-group><journal-title xml:lang="ru">Регионарное кровообращение и микроциркуляция</journal-title><trans-title-group xml:lang="en"><trans-title>Regional blood circulation and microcirculation</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-6655</issn><issn pub-type="epub">2712-9756</issn><publisher><publisher-name>Academician I.P. Pavlov First St. Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/1682-6655-2026-25-1-45-51</article-id><article-id custom-type="elpub" pub-id-type="custom">microcirculation-1521</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ (КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ)</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES (CLINICAL INVESTIGATIONS)</subject></subj-group></article-categories><title-group><article-title>Ангио- и нейропротективный эффект дистантного ишемического прекондиционирования при лечении фокусированным ультразвуком под контролем магнитно-резонансной томографии</article-title><trans-title-group xml:lang="en"><trans-title>Angio- and Neuroprotective Effect of Remote Ischemic Preconditioning in Treatment with Focused Ultrasound under Magnetic Resonance Imaging Guidance</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5158-2707</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мухамадеева</surname><given-names>Н. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Mukhamadeeva</surname><given-names>N. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мухамадеева Наиля Рифхатовна – аспирант кафедры пропедевтики внутренних болезней, Башкирский ГМУ; заместитель главного врача по медицинской части, врач-кардиолог, ООО «Кин» Международный медицинский центр им. В. С. Бузаева</p><p>450008, Уфа, ул. Ленина, д. 3; 450059, Уфа, ул. Рихарда Зорге, д. 17/4</p></bio><bio xml:lang="en"><p>Mukhamadeeva Nailya R. – PhD Student, Department of Propaedeutics of Internal Medicine, Bashkir State Medical University; Deputy Chief Physician for Medical Affairs, Cardiologist, Intelligent Neurosurgery Clinic, Buzaev International Medical Center.</p><p>3, Lenina str., Ufa, 450008; 7/4, Richarda Sorge str., Ufa, 450059</p></bio><email xlink:type="simple">ishtu2013@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9949-9582</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Качемаева</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kachemaeva</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Качемаева Ольга Валерьевна – канд. мед. наук, доцент кафедры неврологии, Башкирский ГМУ; врач-невролог, ООО «Кин» Международный медицинский центр им. В. С. Бузаева.</p><p>450008, Уфа, ул. Ленина, д. 3; 450059, Уфа, ул. Рихарда Зорге, д. 17/4</p></bio><bio xml:lang="en"><p>Kachemaeva Olga V. – Cand. Med. Sci., Associate Professor, Department of Neurology, Bashkir State Medical University; Neurologist, Fntelligent Neurosurgery Clinic, Buzaev Fnternational Medical Center.</p><p>3, Lenina str., Ufa, 450008; 7/4, Richarda Sorge str., Ufa, 450059</p></bio><email xlink:type="simple">olga.kachemaeva@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0511-9345</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бузаев</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Buzaev</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бузаев Игорь Вячеславович – д-р мед. наук, профессор кафедры госпитальной хирургии, Башкирский ГМУ; директор по развитию, врач – сердечно-сосудистый хирург, ООО «Кин» Международный медицинский центр им. В. С. Бузаева.</p><p>450008, Уфа, ул. Ленина, д. 3; 450059, Уфа, ул. Рихарда Зорге, д. 17/4</p></bio><bio xml:lang="en"><p>Buzaev Igor V. – Dr. Med. Sci., Professor, Department of Hospital Surgery, Bashkir State Medical University; Development Director, Cardiovascular Surgeon, Intelligent neurosurgery Clinic, Buzaev International Medical Center.</p><p>3, Lenina str., Ufa, 450008; 7/4, Richarda Sorge str., Ufa, 450059</p></bio><email xlink:type="simple">igor@buzaev.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2758-0351</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Галимова</surname><given-names>Р. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Galimova</surname><given-names>R. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Галимова Резида Маратовна – д-р мед. наук, доцент кафедры нейрохирургии и медицинской реабилитации, Башкирский ГМУ; врач-нейрохирург, ООО «Кин» Международный медицинский центр им. В. С. Бузаева.</p><p>450008, Уфа, ул. Ленина, д. 3; 450059, Уфа, ул. Рихарда Зорге, д. 17/4</p></bio><bio xml:lang="en"><p>Galimova Rezida M. – Dr. Med. Sci., Associate Professor, Department of Neurosurgery and Medical Rehabilitation, Bashkir State Medical University; Neurosurgeon, Intelligent Neurosurgery Clinic, Buzaev International Medical Center.</p><p>3, Lenina str., Ufa, 450008; 7/4, Richarda Sorge str., Ufa, 450059</p></bio><email xlink:type="simple">rezida@galimova.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9876-9202</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лакман</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Lakman</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лакман Ирина Александровна – канд. техн. наук, доцент, заведующий лабораторией исследования социально-экономических проблем регионов.</p><p>450076, Уфа, ул. Заки Валиди, д. 3</p></bio><bio xml:lang="en"><p>Lakman Irina A. – Cand. tech. Sci., Associate Professor, Head, Laboratory for Research of Social and Economic Problems of Regions.</p><p>32, Zaki Validi str., Ufa, 450076</p></bio><email xlink:type="simple">lackmania@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-5508-3201</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Набиева</surname><given-names>З. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Nabieva</surname><given-names>Z. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Набиева Зарина Рамилевна – студент направления 01.03.05 «Статистика».</p><p>450076, Уфа, ул. Заки Валиди, д. 3</p></bio><bio xml:lang="en"><p>Nabieva Zarina R. – Statistics Student.</p><p>32, Zaki Validi str., Ufa, 450076</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9071-8184</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сахаутдинова</surname><given-names>Г. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Sakhautdinova</surname><given-names>G. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сахаутдинова Гюльнар Муратовна – д-р мед. наук, профессор кафедры поликлинической терапии.</p><p>450008, Уфа, ул. Ленина, д. 3</p></bio><bio xml:lang="en"><p>Sakhautdinova Gulnar M. – Dr. Med. Sci., Professor, Department of Polyclinic Therapy.</p><p>3, Lenina str., Ufa, 450008</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9302-499X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Самородов</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Samorodov</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Самородов Александр Владимирович – д-р мед. наук, доцент кафедры фармакологии с курсом клинической фармакологии.</p><p>450008, Уфа, ул. Ленина, д. 3</p></bio><bio xml:lang="en"><p>Samorodov Alexander V. – Dr. Med. Sci., Associate Professor, Department of Pharmacology with Course of Clinical Pharmacology.</p><p>3, Lenina str., Ufa, 450008</p></bio><email xlink:type="simple">AvSamorodov@gmail.com</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2386-6707</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Загидуллин</surname><given-names>Н. Ш.</given-names></name><name name-style="western" xml:lang="en"><surname>Zagidullin</surname><given-names>N. Sh.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Загидуллин Науфаль Шамилевич – д-р мед. наук, профессор, заведующий кафедрой пропедевтики внутренних болезней.</p><p>450008, Уфа, ул. Ленина, д. 3</p></bio><bio xml:lang="en"><p>Zagidullin Naufal Sh. – Dr. Med. Sci., Professor, Head, Department of Propaedeutics of Internal Medicine.</p><p>3, Lenina str., Ufa, 450008</p></bio><email xlink:type="simple">znaufal@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Башкирский государственный медицинский университет» Минздрава России; Общество с ограниченной ответственностью «Клиника интеллектуальной нейрохирургии», Международный медицинский центр имени В.С. Бузаева</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Bashkir State Medical University; Intelligent Neurosurgery Clinic, International Medical Center V.S. Buzaev Memorial</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Уфимский университет науки и технологий»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Ufa University of Science and Technology</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Башкирский государственный медицинский университет» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Bashkir State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>27</day><month>04</month><year>2026</year></pub-date><volume>25</volume><issue>1</issue><fpage>45</fpage><lpage>51</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Мухамадеева Н.Р., Качемаева О.В., Бузаев И.В., Галимова Р.М., Лакман И.А., Набиева З.Р., Сахаутдинова Г.М., Самородов А.В., Загидуллин Н.Ш., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Мухамадеева Н.Р., Качемаева О.В., Бузаев И.В., Галимова Р.М., Лакман И.А., Набиева З.Р., Сахаутдинова Г.М., Самородов А.В., Загидуллин Н.Ш.</copyright-holder><copyright-holder xml:lang="en">Mukhamadeeva N.R., Kachemaeva O.V., Buzaev I.V., Galimova R.M., Lakman I.A., Nabieva Z.R., Sakhautdinova G.M., Samorodov A.V., Zagidullin N.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.microcirc.ru/jour/article/view/1521">https://www.microcirc.ru/jour/article/view/1521</self-uri><abstract><sec><title>Введение</title><p>Введение. Дистантное ишемическое прекондиционирование (ИП) является перспективным инструментом защиты органов и тканей от повреждений.</p><p>Целью данного исследования стало исследование диагностической эффективности ангионейропротективных биомаркеров у пациентов с экстрапирамидными двигательными расстройствами при проведении термоабляции фокусированным ультразвуком под контролем магнитно-резонансной томографии (МР-ФУЗ).</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. В проспективное Рандомизированное слепое исследование с активным контролем (имитация ИП, иИП) было включено 42 пациента. Пациенты до операции были Рандомизированы в группу ИП (давление в манжете равно систолическому давлению + 50 мм рт. ст., n=21) и имитации ИП (давление в манжете равно диастолическому давлению, n=21), ИП/иИП проводились в три цикла по 5 мин воздействия с пятиминутным отдыхом между циклами. Уровни биомаркеров (TRIM72, S100B, убиквитина, Lp-PLA2, эндотелина-1) измеряли в сыворотке крови до и через 1 час после МР-ФУЗ.</p></sec><sec><title>Результаты</title><p>Результаты. При сравнении показателей после МР-ФУЗ выявлены статистически значимые межгрупповые различия: в группе имитации ИП уровень S100B (1,34 нг/мл) был выше, чем в группе ИП (0,44 нг/мл) (p&lt;0,001), а уровень убиквитина (5,8 нг/мл) также превышал показатель группы ИП (4,73 нг/мл) (p=0,008). Полученные данные свидетельствуют о том, что предшествующее ИП ассоциировано с подавлением выброса биомаркеров нейроглиального повреждения (S100B) и протеолитического стресса (убиквитин) в ответ на термоабляцию.</p></sec><sec><title>Вывод</title><p>Вывод. ИП ассоциировано со снижением уровней S100B и убиквитина при проведении МР-ФУЗ-термоабляции и демонстрирует цитопротективное влияние, уменьшая повреждение гематоэнцефалического барьера и нейронов.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. Remote ischemic preconditioning (RIPC) is a promising intervention for protecting organs and tissues from damage.</p><p>The aim of this study was to evaluate the diagnostic efficacy of angioneuroprotective biomarkers in patients with extrapyramidal movement disorders undergoing magnetic resonance-guided focused ultrasound (MRgFUS) thermocoagulation.</p></sec><sec><title>Materials and Methods</title><p>Materials and Methods. 42 patients were enrolled in a prospective, randomized, blinded study with an active control (sham RIPC). Prior to the procedure, patients were randomized into either the RIPC group (cuff pressure set at systolic blood pressure + 50 mm Hg, n=21) or the sham RIPC group (cuff pressure set at diastolic blood pressure, n=21). The protocol in both groups consisted of three 5-minute cycles of the cuff inflation (preconditioning or its imitation) each followed by a 5-minute rest intervals. Levels of biomarkers (TRIM72, S100B, ubiquitin, Lp-PLA2, endothelin-1) were measured in blood serum before and 1 hour after MRgFUS procedure.</p></sec><sec><title>Results</title><p>Results. Comparison of post-procedural biomarker levels revealed statistically significant differences: the S100B levels were higher in the sham RIPC group (1.34 ng/mL) compared to the RIPC group (0.44 ng/mL, p&lt;0.001) and the ubiquitin level (5.8 ng/mL) were also higher than in the RIPC group (4.73 ng/mL) (p = 0.008). These findings indicate that prior RIPC is associated with suppression of biomarkers of neuroglial damage (S100B) and proteolytic stress (ubiquitin) released in response to thermocoagulation.</p></sec><sec><title>Conclusion</title><p>Conclusion. RIPC is associated with reduced levels of S100B and ubiquitin during MRgFUS thermocoagulation, demonstrating a cytoprotective effect by mitigating blood-brain barrier and neuronal damage.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>ишемическое прекондиционирование</kwd><kwd>МР-ФУЗ</kwd><kwd>экстрапирамидные двигательные расстройства</kwd><kwd>биомаркеры</kwd><kwd>S100B</kwd><kwd>убиквитин</kwd></kwd-group><kwd-group xml:lang="en"><kwd>ischemic preconditioning</kwd><kwd>MRgFUS</kwd><kwd>extrapyramidal movement disorders</kwd><kwd>biomarkers</kwd><kwd>S100B</kwd><kwd>ubiquitin</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа выполнена при поддержке Программы стратегического академического лидерства Башкирского государственного медицинского университета (ПРИОРИТЕТ-2030)</funding-statement><funding-statement xml:lang="en">The work was carried out with the support of the Strategic Academic Leadership Program of Bashkir State Medical University (PRIORITY 2030)</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Галимова Р. М., Иллариошкин С. Н., Бузаев И. В., Качемаева О. В. Терапия двигательных нарушений методом фокусированного ультразвука под контролем магнитнорезонансной томографии. Рекомендации для неврологов по отбору пациентов // Бюллетень национального общества по изучению болезни Паркинсона и расстройств движений. 2020. № 9. С. 9–15. Doi:10.24411/2226-079X-2020-12168.</mixed-citation><mixed-citation xml:lang="en">Galimova RM, Illarioshkin SN, Buzaev IV, Kachemaeva OV. Therapy of motor disorders by magnetic resonance-guided focused ultrasound. Guidelines for neurologists on patient selection. Byulleten’ Natsional’nogo obshchestva po izucheniyu bolezni Parkinsona i rasstroistv dvizhenii = Bulletin of the National Society for the Study of Parkinson’s Disease and Movement Disorders. 2020;(9):9–15. (In Russ). Doi:10.24411/2226-079X-2020-12168.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Leporace M, Calabria FF, Siciliano R, et al. The thermal ablation with mrgfus: from physics to oncological applications. Cancers (Basel). 2024;17(1):36. Doi: 10.3390/cancers17010036.</mixed-citation><mixed-citation xml:lang="en">Leporace M, Calabria FF, Siciliano R, et al. The thermal ablation with mrgfus: from physics to oncological applications. Cancers (Basel). 2024;17(1):36. Doi: 10.3390/cancers17010036.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Jia P, Ji Q, Zou Z, et al. Effect of delayed remote ischemic preconditioning on acute kidney injury and outcomes in patients undergoing cardiac surgery: a randomized clinical trial. Circulation. 2024;150(17):1366–1376. Doi: 10.1161/CIRCULATIONAHA.124.071408.</mixed-citation><mixed-citation xml:lang="en">Jia P, Ji Q, Zou Z, et al. Effect of delayed remote ischemic preconditioning on acute kidney injury and outcomes in patients undergoing cardiac surgery: a randomized clinical trial. Circulation. 2024;150(17):1366–1376. Doi: 10.1161/CIRCULATIONAHA.124.071408.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu S, Zheng Z, Lv W, et al. Neuroprotective effect of remote ischemic preconditioning in patients undergoing cardiac surgery: a randomized controlled trial. Front Cardiovasc Med. 2022;9:952033. Doi: 10.3389/fcvm.2022.952033.</mixed-citation><mixed-citation xml:lang="en">Zhu S, Zheng Z, Lv W, et al. Neuroprotective effect of remote ischemic preconditioning in patients undergoing cardiac surgery: a randomized controlled trial. Front Cardiovasc Med. 2022;9:952033. Doi: 10.3389/fcvm.2022.952033.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Wang YF, An ZY, Li JW, et al. MG53/TRIM72: multi-organ repair protein and beyond. Front Physiol. 2024;15:1377025. Doi: 10.3389/fphys.2024.1377025.</mixed-citation><mixed-citation xml:lang="en">Wang YF, An ZY, Li JW, et al. MG53/TRIM72: multi-organ repair protein and beyond. Front Physiol. 2024;15:1377025. Doi: 10.3389/fphys.2024.1377025.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Marenholz I, Heizmann CW, Fritz G. S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun. 2004;322(4):1111–1122. Doi: 10.1016/j.bbrc.2004.07.096.</mixed-citation><mixed-citation xml:lang="en">Marenholz I, Heizmann CW, Fritz G. S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun. 2004;322(4):1111–1122. Doi: 10.1016/j.bbrc.2004.07.096.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Powell SR, Herrmann J, Lerman A, et al. The ubiquitin-proteasome system and cardiovascular disease. Prog Mol Biol Transl Sci. 2012;109:295–346. Doi: 10.1016/B978-0-12397863-9.00009-2.</mixed-citation><mixed-citation xml:lang="en">Powell SR, Herrmann J, Lerman A, et al. The ubiquitin-proteasome system and cardiovascular disease. Prog Mol Biol Transl Sci. 2012;109:295–346. Doi: 10.1016/B978-0-12397863-9.00009-2.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Shen G, Thomas TS, Walpert AR, et al. Role of reninangiotensin-aldosterone system activation and other metabolic variables in relation to arterial inflammation in HIV. Clin Endocrinol (Oxf). 2022;97(5):581–587. Doi: 10.1111/cen.14784.</mixed-citation><mixed-citation xml:lang="en">Shen G, Thomas TS, Walpert AR, et al. Role of reninangiotensin-aldosterone system activation and other metabolic variables in relation to arterial inflammation in HIV. Clin Endocrinol (Oxf). 2022;97(5):581–587. Doi: 10.1111/cen.14784.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Haynes WG, Webb DJ. Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet. 1994; 344(8926):852–854. Doi: 10.1016/s0140-6736(94)92827-4.</mixed-citation><mixed-citation xml:lang="en">Haynes WG, Webb DJ. Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet. 1994; 344(8926):852–854. Doi: 10.1016/s0140-6736(94)92827-4.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Comità S, Rubeo C, Giordano M, et al. Pathways for cardioprotection in perspective: focus on remote conditioning and extracellular vesicles. Biology (Basel). 2023;12(2):308. Doi: 10.3390/biology12020308.</mixed-citation><mixed-citation xml:lang="en">Comità S, Rubeo C, Giordano M, et al. Pathways for cardioprotection in perspective: focus on remote conditioning and extracellular vesicles. Biology (Basel). 2023;12(2):308. Doi: 10.3390/biology12020308.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">D’Ascenzo F, Femminò S, Ravera F, et al. Extracellular vesicles from patients with Acute Coronary Syndrome impact on ischemia-reperfusion injury. Pharmacol Res. 2021;170:105715. Doi: 10.1016/j.phrs.2021.105715.</mixed-citation><mixed-citation xml:lang="en">D’Ascenzo F, Femminò S, Ravera F, et al. Extracellular vesicles from patients with Acute Coronary Syndrome impact on ischemia-reperfusion injury. Pharmacol Res. 2021;170:105715. Doi: 10.1016/j.phrs.2021.105715.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Luca C, Boieriu A, Neculoiu D, Tint D. The impact of remote ischemic preconditioning on inflammation markers in patients undergoing coronary artery bypass grafting. Cardiol Res. 2024;15(5):369–376. Doi: 10.14740/cr1702.</mixed-citation><mixed-citation xml:lang="en">Luca C, Boieriu A, Neculoiu D, Tint D. The impact of remote ischemic preconditioning on inflammation markers in patients undergoing coronary artery bypass grafting. Cardiol Res. 2024;15(5):369–376. Doi: 10.14740/cr1702.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Wang H, Lyu Y, Liao Q, et al. Effects of remote ischemic preconditioning in patients undergoing off-pump coronary artery bypass graft surgery. Front Physiol. 2019;10:495. Doi: 10.3389/fphys.2019.00495.</mixed-citation><mixed-citation xml:lang="en">Wang H, Lyu Y, Liao Q, et al. Effects of remote ischemic preconditioning in patients undergoing off-pump coronary artery bypass graft surgery. Front Physiol. 2019;10:495. Doi: 10.3389/fphys.2019.00495.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Gorjipour F, Saeedzadeh T, Toloueitabar Y, et al. Remote ischemic preconditioning effects on inflammatory markers and myocardial protection in coronary artery bypass graft surgery. Perfusion. 2022;37(1):56–61. Doi: 10.1177/0267659120979293.</mixed-citation><mixed-citation xml:lang="en">Gorjipour F, Saeedzadeh T, Toloueitabar Y, et al. Remote ischemic preconditioning effects on inflammatory markers and myocardial protection in coronary artery bypass graft surgery. Perfusion. 2022;37(1):56–61. Doi: 10.1177/0267659120979293.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Graham EM, Burd I, Everett AD, Northington FJ. Blood biomarkers for evaluation of perinatal encephalopathy. Front Pharmacol. 2016;7:196. Doi: 10.3389/fphar.2016.00196.</mixed-citation><mixed-citation xml:lang="en">Graham EM, Burd I, Everett AD, Northington FJ. Blood biomarkers for evaluation of perinatal encephalopathy. Front Pharmacol. 2016;7:196. Doi: 10.3389/fphar.2016.00196.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Meroni G, Diez-Roux G. TRIM/RBCC, a novel class of ‘single protein RING finger’ E3 ubiquitin ligases. Bioessays. 2005;27(11):1147–1157. Doi: 10.1002/bies.20304.</mixed-citation><mixed-citation xml:lang="en">Meroni G, Diez-Roux G. TRIM/RBCC, a novel class of ‘single protein RING finger’ E3 ubiquitin ligases. Bioessays. 2005;27(11):1147–1157. Doi: 10.1002/bies.20304.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Reymond A, Meroni G, Fantozzi A, et al. The tripartite motif family identifies cell compartments. EMBO J. 2001;20(9):2140–2151. Doi: 10.1093/emboj/20.9.2140.</mixed-citation><mixed-citation xml:lang="en">Reymond A, Meroni G, Fantozzi A, et al. The tripartite motif family identifies cell compartments. EMBO J. 2001;20(9):2140–2151. Doi: 10.1093/emboj/20.9.2140.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Ponting C, Schultz J, Bork P. SPRY domains in ryanodine receptors (Ca(2+)-release channels). Trends Biochem Sci. 1997;22(6):193–194. Doi: 10.1016/s0968-0004(97)01049-9.</mixed-citation><mixed-citation xml:lang="en">Ponting C, Schultz J, Bork P. SPRY domains in ryanodine receptors (Ca(2+)-release channels). Trends Biochem Sci. 1997;22(6):193–194. Doi: 10.1016/s0968-0004(97)01049-9.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Žurek J, Fedora M. The usefulness of S100B, NSE, GFAP, NF-H, secretagogin and Hsp70 as a predictive biomarker of outcome in children with traumatic brain injury. Acta Neurochir (Wien). 2012;154(1):93–103. Doi: 10.1007/s00701-011-1175-2.</mixed-citation><mixed-citation xml:lang="en">Žurek J, Fedora M. The usefulness of S100B, NSE, GFAP, NF-H, secretagogin and Hsp70 as a predictive biomarker of outcome in children with traumatic brain injury. Acta Neurochir (Wien). 2012;154(1):93–103. Doi: 10.1007/s00701-011-1175-2.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Churchill EN, Ferreira JC, Brum PC, et al. Ischaemic preconditioning improves proteasomal activity and increases the degradation of deltaPKC during reperfusion. Cardiovasc Res. 2010;85(2):385–394. Doi: 10.1093/cvr/cvp334.</mixed-citation><mixed-citation xml:lang="en">Churchill EN, Ferreira JC, Brum PC, et al. Ischaemic preconditioning improves proteasomal activity and increases the degradation of deltaPKC during reperfusion. Cardiovasc Res. 2010;85(2):385–394. Doi: 10.1093/cvr/cvp334.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Powell SR, Wang P, Katzeff H, et al. Oxidized and ubiquitinated proteins may predict recovery of postischemic cardiac function: essential role of the proteasome. Antioxid Redox Signal. 2005;7(5-6):538–546. Doi: 10.1089/ars.2005.7.538.</mixed-citation><mixed-citation xml:lang="en">Powell SR, Wang P, Katzeff H, et al. Oxidized and ubiquitinated proteins may predict recovery of postischemic cardiac function: essential role of the proteasome. Antioxid Redox Signal. 2005;7(5-6):538–546. Doi: 10.1089/ars.2005.7.538.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
